Nanomedicine/materdicine-enabled sonocatalytic therapy

Adv Drug Deliv Rev. 2024 Feb:205:115160. doi: 10.1016/j.addr.2023.115160. Epub 2023 Dec 17.

Abstract

The advent of numerous treatment modalities with desirable therapeutic efficacy has been made possible by the fast development of nanomedicine and materdicine, among which the ultrasound (US)-triggered sonocatalytic process as minimal or non-invasive method has been frequently employed for diagnostic and therapeutic purposes. In comparison to phototherapeutic approaches with inherent penetration depth limitations, sonocatalytic therapy shatters the depth limit of photoactivation and offers numerous remarkable prospects and advantages, including mitigated side effects and appropriate tissue-penetration depth. Nevertheless, the optimization of sonosensitizers and therapies remains a significant issue in terms of precision, intelligence and efficiency. In light of the fact that nanomedicine and materdicine can effectively enhance the theranostic efficiency, we herein aim to furnish a cutting-edge review on the latest progress and development of nanomedicine/materdicine-enabled sonocatalytic therapy. The design methodologies and biological features of nanomedicine/materdicine-based sonosensitizers are initially introduced to reveal the underlying relationship between composition/structure, sonocatalytic function and biological effect, in accompany with a thorough discussion of nanomedicine/materdicine-enabled synergistic therapy. Ultimately, the facing challenges and future perspectives of this intriguing sonocatalytic therapy are highlighted and outlined to promote technological advancements and clinical translation in efficient disease treatment.

Keywords: Catalytic biomaterials; Materdicine; Sonocatalytic; Sonosensitizer; Ultrasound.

Publication types

  • Review

MeSH terms

  • Humans
  • Nanomedicine
  • Neoplasms* / therapy
  • Precision Medicine
  • Theranostic Nanomedicine / methods
  • Ultrasonic Therapy*
  • Ultrasonography